No connection

Search Results

GIL

NEUTRAL
$57.86 Live
Gildan Activewear Inc. · NYSE
Target $83.11 (+43.6%)
$41.61 52W Range $73.7

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 28, 2026
Market cap
$10.72B
P/E
22.51
ROE
15.7%
Profit margin
11.0%
Debt/Equity
1.32
Dividend yield
1.72%

AI Analysis

AI-powered fundamental assessment

Confidence
85%
Gildan Activewear presents a conflicted profile with a Piotroski F-Score of 4/9, indicating stable but mediocre financial health. While the company shows impressive revenue growth of 31.30%, this is starkly contrasted by a severe earnings collapse of -59.20% YoY. The stock is trading at a significant premium to its Graham Number ($33.35) and Intrinsic Value ($17.99), though a low PEG ratio of 0.49 and a bullish analyst target of $83.11 suggest the market is pricing in a strong recovery.

Key Strengths

Strong top-line revenue growth (31.30% YoY)
Healthy operating margins of 20.67%
Consistent track record of beating earnings estimates (3/4 last 4 quarters)
Very attractive PEG ratio (0.49) suggesting growth is undervalued
Sustainable dividend payout ratio (35.18%)

Key Risks

Severe decline in YoY earnings growth (-59.20%)
Significant valuation gap between current price ($57.86) and Graham Number ($33.35)
Poor short-term liquidity indicated by a Quick Ratio of 0.59
Bearish technical trend (0/100 score)
Relatively high Debt/Equity ratio of 1.32
AI Fair Value Estimate
Based on comprehensive analysis
$41.5
-28.3% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
56
Moderate
Value
35
Future
60
Past
75
Health
45
Dividend
65
AI Verdict
Speculative Hold
Key drivers: Revenue growth vs Earnings contraction, Valuation premium over deterministic baselines, Strong analyst optimism
Confidence
80%
Value
35/100

Ref P/E 22.51, PEG 0.49, Graham $33.35

Positives
  • Low PEG ratio
  • Forward P/E (10.77) is significantly lower than current P/E
Watchpoints
  • Price is 74% above Graham Number
  • Price is 222% above Intrinsic Value
Future
60/100

Ref Growth rates and Analyst Targets

Positives
  • Robust YoY and Q/Q revenue growth (>31%)
  • High analyst target price ($83.11)
Watchpoints
  • Negative earnings growth trend
  • Bearish technical momentum
Past
75/100

Ref Historical price and earnings track record

Positives
  • Strong 5-year price appreciation (+81.8%)
  • Consistent history of EPS surprises
Watchpoints
  • Recent 6-month price decline (-4.8%)
Health
45/100

Ref Piotroski F-Score 4/9, Debt/Equity 1.32

Positives
  • Current ratio is healthy at 2.11
Watchpoints
  • Piotroski F-Score is only 4/9
  • Quick ratio (0.59) suggests reliance on inventory for liquidity
Dividend
65/100

Ref Yield 1.72%, Payout 35.18%

Positives
  • Low payout ratio (35.18%) provides safety
  • Consistent annual dividend rate
Watchpoints
  • Relatively low yield (1.72%)

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$57.86
Analyst Target
$83.11
Upside/Downside
+43.6%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for GIL and closest competitors.

Updated 2026-04-27
GIL
Gildan Activewear Inc.
Primary
5Y
+81.8%
3Y
+87.9%
1Y
+37.4%
6M
-4.8%
1M
+6.3%
1W
-3.1%
DKN
DraftKings Inc.
Peer
5Y
-65.6%
3Y
+11.7%
1Y
-34.9%
6M
-42.2%
1M
-9.2%
1W
-7.2%
TXR
Texas Roadhouse, Inc.
Peer
5Y
+74.6%
3Y
+53.9%
1Y
+2.6%
6M
-8.8%
1M
-3.7%
1W
-2.0%
CHW
Chewy, Inc.
Peer
5Y
-68.5%
3Y
-16.7%
1Y
-27.8%
6M
-25.9%
1M
-2.1%
1W
-5.5%
WYN
Wynn Resorts, Limited
Peer
5Y
-12.9%
3Y
-4.9%
1Y
+34.7%
6M
-15.4%
1M
+2.8%
1W
-1.1%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
22.51
Forward P/E
10.77
PEG Ratio
0.49
P/B Ratio
3.01
P/S Ratio
2.96
EV/Revenue
4.16
EV/EBITDA
16.7
Market Cap
$10.72B

Profitability

Profit margins and return metrics

Profit Margin 11.02%
Operating Margin 20.67%
Gross Margin 32.2%
ROE 15.7%
ROA 6.86%

Growth

Revenue and earnings growth rates

Revenue Growth +31.3%
Earnings Growth -59.2%
Q/Q Revenue Growth +31.28%
Q/Q Earnings Growth -57.6%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
1.32
Moderate
Current Ratio
2.11
Strong
Quick Ratio
0.59
Poor
Cash/Share
$1.91

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$1.1B
Gross Margin
28.9%
Op. Margin
17.3%
Net Margin
5.2%
Total Assets
$10.5B
Liabilities
$6.9B
Equity
$3.6B
Debt/Equity
1.94x
Operating CF
$0.3B
CapEx
$-0.0B
Free Cash Flow
$0.3B
FCF Yield
91%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-04-30
$N/A
2026-02-26
$0.96
+0.8% surprise
2025-10-29
$1.0
+2.2% surprise
2025-07-31
$0.97
+1.6% surprise

Consumer Cyclical Sector Comparison

Comparing GIL against 382 companies in the Consumer Cyclical sector (23 bullish, 130 neutral, 229 bearish)
P/E Ratio
22.51
This Stock
vs
34.07
Sector Avg
-33.9% (Discount)
Return on Equity (ROE)
15.7%
This Stock
vs
-44.5%
Sector Avg
-135.3% (Below Avg)
Profit Margin
11.02%
This Stock
vs
-5.47%
Sector Avg
-301.3% (Weaker)
Debt to Equity
1.32
This Stock
vs
1.52
Sector Avg
-13.1% (Lower)
Revenue Growth
31.3%
This Stock
vs
28.89%
Sector Avg
+8.3% (Growing)
Current Ratio
2.11
This Stock
vs
2.44
Sector Avg
-13.6% (Weaker)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

Abou El Assal (Rabih)
Senior Officer of Issuer
Buy
2026-04-13
167 shares · $10,063
De Haan (Jason)
Senior Officer of Issuer
Buy
2026-04-13
102 shares · $6,042
Hayem (Jessy)
Senior Officer of Issuer
Buy
2026-04-13
68 shares · $3,972
Maisonneuve (Patrice)
Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Buy
2026-04-13
53 shares · $3,117
Moussalli (Jad)
Senior Officer of Issuer
Buy
2026-04-13
116 shares · $6,776
Fritchman Merkel (Ann)
Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Stock Award
2026-03-31
Barnhart (Lindsay Cassels)
Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Option Exercise
2026-03-26
148 shares · $8,218
Deans (Tanya)
Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Option Exercise
2026-03-26
758 shares · $42,091
Mayer (Roberto)
Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Option Exercise
2026-03-26
436 shares · $24,211
Newman (Jane Margaret)
Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Option Exercise
2026-03-26
411 shares · $22,822
Powell (Jaye)
Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Option Exercise
2026-03-26
316 shares · $17,547
Wilson (Ryan James)
Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Option Exercise
2026-03-26
276 shares · $15,326
Adams (Suzanne)
Senior Officer of Issuer
Stock Award
2026-03-19
Spadafora (Vincent)
Senior Officer of Issuer
Stock Award
2026-03-18
Barnhart (Lindsay Cassels)
Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Option Exercise
2026-03-17
174 shares · $10,222
Insider transactions can signal confidence or concerns about company prospects

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
BUY
9 analysts
Scotiabank
2026-03-02
Maintains
Sector Outperform Sector Outperform
RBC Capital
2026-03-02
Maintains
Outperform Outperform
RBC Capital
2026-02-24
Maintains
Outperform Outperform
Scotiabank
2026-02-03
Maintains
Sector Outperform Sector Outperform
BMO Capital
2026-01-26
Maintains
Outperform Outperform
UBS
2025-12-16
Maintains
Buy Buy
UBS
2025-10-31
Maintains
Buy Buy
Scotiabank
2025-10-30
Maintains
Sector Outperform Sector Outperform
Barclays
2025-10-30
Maintains
Overweight Overweight

Past News Coverage

Recent headlines mentioning GIL from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile